Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE
-
Published:2024-04
Issue:4
Volume:9
Page:102971
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Cartwright E.ORCID,
Slater S.ORCID,
Saffery C.,
Tran A.,
Turkes F.ORCID,
Smith G.,
Aresu M.,
Kohoutova D.ORCID,
Terlizzo M.,
Zhitkov O.ORCID,
Rana I.,
Johnston E.W.ORCID,
Sanna I.,
Smyth E.,
Mansoor W.,
Fribbens C.,
Rao S.,
Chau I.,
Starling N.,
Cunningham D.ORCID